Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Ankle Robot to Reduce Foot Drop in Stroke

8 mai 2020 mis à jour par: VA Office of Research and Development

Adaptive Ankle Robot Control System to Reduce Foot-drop in Chronic Stroke

Deficits in ankle control after stroke can lead to foot drop, resulting in inefficient, aberrant gait and an elevated falls risk. Using a novel ankle robot and newly invented adaptive control system, this study tests whether robotic-assisted treadmill training will improve gait and balance functions in chronic stroke survivors with foot drop impairment. It is hypothesized that, compared to treadmill training alone, integrating adaptive ankle robotics with treadmill training will reduce drop foot during independent overground walking, resulting in greater mobility, improved postural control, and reduced fall risk.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

This proposal investigates a novel ankle robot (anklebot) adaptive control approach integrated with treadmill training to reduce foot drop and improve mobility function in chronic hemiparetic stroke survivors. Currently, stroke survivors with foot drop are trained to live with a cane or other assistive device, and often ankle foot orthotics (AFOs) for safety. Neither mediates task-practice or neuromotor recovery.

The investigators have developed an adaptive anklebot controller that detects gait cycle sub-events for precise timing of graded robotics assistance to enable deficit severity-adjusted ankle motor learning in the context of walking. The investigators' pilot findings show that 6 weeks treadmill training with anklebot (TMR) timed to assist swing phase dorsiflexion only is more effective than treadmill alone (TM) to improve free-walking swing dorsiflexion at foot strike, floor-walking speed, and the benefits are retained at 6 weeks post-training. Notably, swing-phase TMR training improved paretic leg push-off, and reduced center-of-pressure sway on standing balance, indicating potential benefits to other elements of gait and balance, beyond those robotically targeted toward foot drop.

This randomized study investigates the hypothesis that 6 weeks TMR is more effective to improve durably gait biomechanics, static, and dynamic balance, and mobility function in chronic stroke survivors with dorsiflexion deficits, compared to TM alone. Aims are to determine the compare effectiveness of 6 weeks TMR vs. TM alone on:

  1. Independent gait function indexed by gait velocity, swing-phase DF (dorsiflexion), terminal stance push-off.
  2. Balance function indexed by measures of postural sway (CoP), asymmetric loading in quiet standing, peak paretic A-P forces in non-paretic gait initiation, and standardized scales for balance and fall risk.
  3. Long-term mobility outcomes, assessed by repeated measures of all key gait and balance outcomes at 6 weeks and 3 months after formal training cessation.

Type d'étude

Interventionnel

Inscription (Réel)

45

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

  • États-Unis
    • Maryland
      • Baltimore, Maryland, États-Unis, 21201
        • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Ischemic or hemorrhagic stroke > 2 months prior in men or women
  • Residual hemiparesis of the lower extremity that includes symptoms of foot drop
  • Capable of ambulating on a treadmill with handrail support
  • Already completed all conventional physical therapy
  • Adequate language and cognitive function to provide informed consent and participate in testing and training

Exclusion Criteria:

  • Cardiac history of:

    • Unstable angina
    • Recent (< 3 months) myocardial infarction
    • Congestive heart failure (NYHA category II or higher)
    • Hemodynamic valvular dysfunction
    • Hypertension that is a contraindication for a bout of treadmill training (>160/100 mmHg on two assessments)

  • Medical history of:

    • Recent hospitalization (< 3 months) for any serious condition leading to significant bed-rest or reduction in mobility function
    • Symptomatic peripheral arterial occlusive disease
    • Orthopedic or chronic pain conditions restricting exercise
    • Pulmonary failure requiring oxygen
    • Uncompensated renal failure
    • Active cancer

  • Neurological history and exam consistent with:

    • Dementia
    • Receptive or global aphasia that confounds testing and training, operationally defined as unable to follow 2-point commands
    • Non-stroke neurological disorder restricting exercise (e.g. Parkinson's Syndrome, myopathy)
    • Untreated major depression

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Treadmill+anklebot
This group will receive gait training on a treadmill while wearing the anklebot with the adaptive control system.
Dispositif: Treadmill plus anklebot
This intervention employs the use of the adaptive anklebot control system to complement treadmill exercise training over a 6-week intervention period.
Autres noms:
  • TMR
Comparateur actif: Treadmill only
This group will receive gait training on a treadmill, without use of the anklebot.
Comportemental: Treadmill only
This intervention employs the use of a treadmill for gait exercise training over a 6-week intervention period
Autres noms:
  • MT

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Gait Velocity During Self-selected Overground Walking
Délai: Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months after completion
Gait velocity during self-selected overground walking measured in cm/sec
Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months after completion
Anterior-posterior Propulsion Forces of Paretic Side During Gait
Délai: Change from baseline to: Post 6-weeks training, 6 weeks after completion, and 3 (or 6) months
Newtons: anterior-posterior force generated during push-off phase of the gait cycle
Change from baseline to: Post 6-weeks training, 6 weeks after completion, and 3 (or 6) months
Peak Dorsiflexion Angle During Swing Phase of Gait
Délai: Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months after completion
Degrees; extent of ankle dorsiflexion to enable foot clearance
Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months after completion
Postural Sway Areas During Quiet Standing
Délai: Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months
cm^2; extent of postural deviations to assess static postural control
Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months
Ratio of Asymmetric Loading in Quiet Standing
Délai: Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months
Ratio of Newtons of force per each leg (paretic/nonparetic) while standing quietly
Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months
Peak Paretic Push Off Forces During Gait Initiation
Délai: Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months
Newtons; magnitude of forward ground reaction forces
Change from baseline to: Post 6-week training, 6 weeks after completion, and 3 (or 6) months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

VA Office of Research and Development

Les enquêteurs

  • Chercheur principal: Steven J Kittner, Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 septembre 2015

Achèvement primaire (Réel)

1 avril 2019

Achèvement de l'étude (Réel)

30 juin 2019

Dates d'inscription aux études

Première soumission

19 juin 2015

Première soumission répondant aux critères de contrôle qualité

24 juin 2015

Première publication (Estimation)

29 juin 2015

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

20 mai 2020

Dernière mise à jour soumise répondant aux critères de contrôle qualité

8 mai 2020

Dernière vérification

1 mai 2020

Plus d'information

Termes liés à cette étude

Mots clés

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • N1699-R

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Oui

produit fabriqué et exporté des États-Unis.

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner